Institutional Ownership
Pelthos Therapeutics Inc
CUSIP 171126204COM SHSPTHSQ1 2026
13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
49.9%
Max % of class reported
Institutional Holders
15
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
9 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Ikarian Capital, LLC | 13G/A | 11.0% | 255.8K | SEC |
| 2 | Feb 5, 2026 | 3i, LP | 13G/A | 10.0% | 318.9K | SEC |
| 3 | Nov 14, 2025 | Murchinson Ltd. | 13G | 9.1% | 280.0K | SEC |
| 4 | Nov 14, 2025 | Ikarian Capital, LLC | 13G/A | 11.0% | 186.4K | SEC |
| 5 | Nov 10, 2025 | Ligand Pharmaceuticals Incorporated | 13D/A | 49.9% | — | SEC |
| 6 | Aug 13, 2025 | Ame Equities LLC | 13G/A | — | — | SEC |
| 7 | Jul 8, 2025 | 3i, LP | 13G | 9.9% | 303.1K | SEC |
| 8 | Jul 3, 2025 | Ezra Friedberg | 13D/A | 8.3% | — | SEC |
| 9 | Jul 3, 2025 | Ligand Pharmaceuticals Incorporated | 13D | 49.9% | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Murchinson Ltd. | 296.3K | $6.23M |
| 2 | Ikarian Capital, LLC | 256.6K | $5.39M |
| 3 | Boothbay Fund Management, LLC | 81.9K | $1.72M |
| 4 | J. Goldman & Co LP | 50.4K | $1.06M |
| 5 | Cantor Fitzgerald, L. P. | 41.4K | $870.3K |
| 6 | Diadema Partners LP | 24.8K | $520.5K |
| 7 | Knott David M Jr | 21.1K | $442.7K |
| 8 | Geode Capital Management, LLC | 15.3K | $321.2K |
| 9 | Pale Fire Capital Se | 12.9K | $271.4K |
| 10 | Persistent Asset Partners Ltd | 6.0K | $126.2K |